A retrospective investigation of the platelet-to-lymphocyte ratio as a potential indicator in early rheumatoid arthritis

Read full text Summarise with VIRAT
Authors: Jingfang Shen, Lianju Li, Lina Leng, Junfeng Li, Xiangzhuo Zhao, Xiaoli Li
Cited by: 0
References: 50

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background The platelet-to-lymphocyte ratio (PLR) has been suggested as a biomarker for inflammation and disease activity in rheumatoid arthritis (RA). However, current findings on its correlation with the Disease Activity Score 28 (DAS28) remain inconsistent. This study aimed to explore the correlation between PLR and DAS28. Methods This retrospective study analyzed 433 consecutive inpatients with early RA at Xingtai People’s Hospital between January 2022 and January 2024. Of these, 72.06% were women, with a mean age of 52.52 ± 14.20 years. All patients met the 2010 American College of Rheumatology/European League Against Rheumatism criteria and had symptoms

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
PeerJ
Volume
14
Pages
e21004–e21004
Publication date
31 March 2026
Language
EN